| Literature DB >> 31502185 |
Chun-Hong Zhang1, Xiao Yang2, Jing-Ran Wei2, Na-Mu-Han Chen1, Jian-Ping Xu1, Ya-Qiong Bi3, Min Yang1, Xue Gong1, Zi-Yan Li1, Kai Ren1, Qi-Heng Han1, Lei Zhang2, Xue Li2, Ming-Yue Ji1, Cong-Cong Wang1, Min-Hui Li4,5.
Abstract
Radix Astragali (RA), a traditional Chinese medicine from the dried root of Astragalus species, is widely distributed throughout the temperate regions of the world. The major bioactive constituents of RA are triterpene glycosides, flflavonoids, saponins, and alkaloids, and these compounds mostly exert pharmacological activities on the cardiovascular, immune, respiratory, and hepatic systems. This review summarizes the recent studies on RA and provides a comprehensive summary regarding the status of resources, ethnopharmacology, phytochemistry, pharmacology, toxicology, clinical application, and patent release of RA. We hope this review can provide a guidance for further development of therapeutic agents from RA.Entities:
Keywords: Radix Astragali; clinical application; ethnopharmacology; pharmacology; phytochemistry; review
Year: 2019 PMID： 31502185 DOI： 10.1007/s11655-019-3032-8
Source DB: PubMed Journal: Chin J Integr Med ISSN： 1672-0415 Impact factor: 1.978